In addition, we speculate that by down-regulating the mTOR gene, these mirnas could perhaps counteract the over-activation of the mTOR pathway that is seen in diseases such as Lymphangioleiomyomatosis (LAM) and certain cancers. This evidence concerns the gene MTOR and cancer.